Whitsett J A, Darovec-Beckerman C, Pollinger J, Moore J J
Pediatr Res. 1982 May;16(5):381-7. doi: 10.1203/00006450-198205000-00013.
Beta-Adrenergic receptors were identified in membrane fractions of rat lung with the beta-adrenergic antagonists (-)-[3H]-dihydroalprenolol (-)-[3H]DHA) and (+/-)-[125I]-iodohydroxybenzylpindolol ((+/-)-[125I]HYP). Binding capacity (Bmax) for (-)-[3H]DHA increased progressively from 46 +/- 7 on day 18 of gestation to 510 +/- 70 femtomoles . mg-1 protein (mean +/- S.D.) on postnatal day 28, at which time adult Bmax was attained. An increase in (-)-[3H]DHA binding capacity of the lung was observed between postnatal days 15 and 28, during the known period of increased thyroid gland secretory activity, serum triiodothyronine (T3), and thyroxine (T4) concentrations in the rat. We therefore studied lung beta-adrenergic receptors in rat pups made hypothyroid with propylthiouracil (PTU) (in utero and postnatally) compared to normal age-matched control pups and to euthyroid pups which were treated with PTU but were also injected daily with thyroxine (T4-treated). Hypothyroid pups grew nearly normally until postnatal day 15 but grew poorly thereafter; but day 28 somatic and lung weight, lung DNA, and protein were markedly decreased in hypothyroid pups as compared to controls. Pulmonary beta-adrenergic receptors were similar in hypothyroid pups and controls on day 15, but were markedly decreased in hypothyroid pups on day 28 (294 +/- 57 versus 489 +/- 82 femtomoles . mg-1 protein in T4 treated euthyroid controls). Treatment of the hypothyroid pups with T4 on day 25 significantly increased lung beta-adrenergic receptors to near normal concentrations by day 28. We conclude that thyroid hormones or thyroid dependent factors enhance pulmonary beta-adrenergic receptor synthesis and that thyroid hormone is required for the normal postnatal maturation of the beta-adrenergic receptor system in the rat lung.
利用β-肾上腺素能拮抗剂(-)-[³H]-二氢心得舒(-)-[³H]DHA)和(±)-[¹²⁵I]-碘羟基苄基吲哚洛尔((±)-[¹²⁵I]HYP),在大鼠肺的膜组分中鉴定出β-肾上腺素能受体。(-)-[³H]DHA的结合容量(Bmax)从妊娠第18天的46±7逐渐增加到出生后第28天的510±70飞摩尔·毫克⁻¹蛋白质(平均值±标准差),此时达到成年大鼠的Bmax。在大鼠甲状腺分泌活动增加、血清三碘甲状腺原氨酸(T3)和甲状腺素(T4)浓度升高的已知时期内,观察到出生后第15天至28天期间肺的(-)-[³H]DHA结合容量增加。因此,我们研究了用丙硫氧嘧啶(PTU)(在子宫内和出生后)使甲状腺功能减退的大鼠幼崽的肺β-肾上腺素能受体,并与年龄匹配的正常对照幼崽以及用PTU治疗但每天也注射甲状腺素的甲状腺功能正常的幼崽(T4治疗组)进行比较。甲状腺功能减退的幼崽在出生后第15天之前生长几乎正常,但此后生长不佳;与对照组相比,甲状腺功能减退的幼崽在出生后第28天的体重、肺重量、肺DNA和蛋白质明显减少。甲状腺功能减退的幼崽和对照组在出生后第15天的肺β-肾上腺素能受体相似,但在出生后第28天,甲状腺功能减退的幼崽的受体明显减少(294±57与T4治疗的甲状腺功能正常对照组的489±82飞摩尔·毫克⁻¹蛋白质相比)。在出生后第25天用T4治疗甲状腺功能减退的幼崽,到出生后第28天,肺β-肾上腺素能受体显著增加至接近正常浓度。我们得出结论,甲状腺激素或甲状腺依赖性因子可增强肺β-肾上腺素能受体的合成,并且甲状腺激素是大鼠肺中β-肾上腺素能受体系统正常出生后成熟所必需的。